HLA genetics and disease with particular reference to Type 1 diabetes and HIV infection in Asian Indians

Expert Review of Clinical Immunology

Volumn 2, Issue 6, 2006, Pages 901-913

  Mehra, Narinder ^a   Kaur, Gurvinder ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Disease association; Genetic diversity; HLA haplotypes; Linkage; Major histocompatibilit complex; Type 1 diabetes

Indexed keywords

EID: 44649136795     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2.6.901     Document Type: Review

References (52)

1. Stewart CA, Horton R, Allcock RJ et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res. 14, 1176-1187(1999). (Pubitemid 38811554)
2. Horton RL, Wilming V, Rand RC et al. Map of the extended human MHC. Nat. Rev. Genet. (2004).
3. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL and Wiley DC, Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329, 506-512 (1987). (Pubitemid 17131093)
4. Bjorkman PJ, Saper MA, Samraoni B, Bennett WS, Strominger JL, Wiley DC, The foreign antigen binding site and T-cell recognition region of class I histocompatibility antigens. Nature 329, 512-518 (1987). (Pubitemid 17131094)
5. Garrett T, Saper M, Bjorkman P, Strominger J, Wiley D. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342, 692-296 (1989).
6. Saper MA, Bjorkman PJ, Wiley DC Refined structure of the human histocompatibility antigen HLA-A2 at 2.6A resolution. J. Mol. Biol. 219(2), 277-319 (1991).
7. Scott CA, Peterson PA, Teyton L, Wilson IA. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8(3), 319-29 (1998). (Pubitemid 28188892)
8. Sidney J, Grey HM, Southwood S, et al. Definition of an HLA-A3 like supermotif demonstrates the overlapping peptide binding repertoires of common HLA molecules. Hum. Immunol. 45, 79-93 (1996). (Pubitemid 26120016)
9. Sette A, Sidney J Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50, 201-212 (1999). (Pubitemid 30099525)
10. Lund O, Nielsen M, Kesmir C et al. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55, 797-810 (2004). (Pubitemid 38650985)
11. Doytchinova IA, Guan P, Flower DR. Identifying human MHC supertypes using bioinformatic methods. J. Immunol. 172, 4314-4323 (2004). (Pubitemid 38375246)
12. Little AM, Parham P. Polymorphism and evolution of HLA class I and II genes and molecules. Rev. Immunogen. 1, 105-123 (1999).
13. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations. Tissue Antigens 64, 631-649 (2004). (Pubitemid 39628044)
14. Lie BA, Thorsby E. Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr. Opin. Immunol. 17, 526-531 (2005). (Pubitemid 41213322)
15. Martin PM, Carrington M. Immunogenetics of viral infections. Curr. Opin. Immunol. 17, 510-516 (2005). (Pubitemid 41207955)
16. McCluskey J, Peh CA, The human leucocyte antigens and clinical medicine: an overview. Rev. Immunogen. 1, 3-20 (1999).
17. Dawkins R, Leelayuwat C, Gauderi S et al. Genomics of the major histocompatiblity complex: haplotypes, duplication, retroviruses and disease. Immunol. Rev. 167, 275-304 (1999). (Pubitemid 29178988)
18. Tiwari JL, Terasaki PI. HLA antigens associated with diseases. In: Anonymous HLA and Disease Associations. Springer, New York, USA, 42-48 (1985).
19. Thorsby E. Invited anniversary review: HLA associated diseases Hum. Immunol. 53, 1-11 (1997). (Pubitemid 27175988)
20. Lechler R, Warrens A (Eds). HLA in health and disease, 2nd Edition. Academic Press, San Diego, USA, 139-146 (2000).
21. Hall FC, Bowness P. HLA and disease: from molecular function to disease association? In: HLA and MHC: Genes, Molecules and Function, Browning MJ, McMichael AJ (Eds), BIOS Scientific Publishers Ltd, Oxford, UK (1996).
22. Hamosh A, Scott AF, Amberger J et al. Online Mendelian Inheritance in Man (OMIM). Hum. Mum. 15, 57-61 (2000). (Pubitemid 30036170)
23. Becker KG, Barnes KC, Bright TJ et al. The genetic association database. Nat. Genet. 36, 431-432 (2004).
24. Polansky H. Microcompetition with Foreign DNA and the Origin of Chronic Disease. CBCD Publishing, New York, USA (2003).
25. Mehra NK, Kaur G, Kanga U, Tandon N. Immunogenetics of autoimmune diseases in Asian Indians. Ann. NY Acad. Sci. 958, 333-336 (2002). (Pubitemid 34592257)
26. Witt CS, Price P, Kaur G et al. The common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe. Tissue Antigens 60, 474-480 (2002). (Pubitemid 36177269)
27. Kanga U, Vaidyanathan B, Jaini R, Menon PS, Mehra NK. HLA haplotypes associated with type 1 diabetes mellitus in North Indian children. Hum. Immunol. 65, 47-53 (2004). (Pubitemid 38209934)
28. Rani R, Sood A, Lazaro A, Stastny P. Associations of MHC class II alleles with insulin dependent diabetes mellitus (IDDM) in patients from North India. Hum. Immunol. 60, 524-531 (1999). (Pubitemid 29296309)
29. Rani R, Sood A, Goswami R. Molecular basis of predisposition to develop type 1 diabetes mellitus in North Indians. Tissue Antigens 64, 145-155 (2004). (Pubitemid 38969578)
30. Kaur G, Sarkar N, Bhatnagar S et al. Pediatric celiac disease in India is associated with multiple DR3-DQ2 haplotypes. Hum. Immunol. 63, 677-682 (2002). (Pubitemid 34816111)
31. Cucca F, Lampis R et al. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum. Mol. Genet. 10, 2025-2037 (2001). (Pubitemid 32998815)
32. *0401) complexed with a peptide from human collagen II. Immunity 7, 473-481 (1997). (Pubitemid 27508699)
33. Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat. Immunol. 2, 501-507 (2001). (Pubitemid 33705851)
34. *04 and its associated haplotypes in the north Indian population. Hum. Immunol. 63, 24-29 (2002). (Pubitemid 34074633)
35. Awata T, Kuzuya T, Matsuda A et al. High frequency of aspartic acid at position 57 of HLA-DQ β chain in Japanese IDDM patients and non-diabetic subjects. Diabetes 39, 266-269 (1990). (Pubitemid 20054297)
36. Stern LJ, Brown JH, Jardetzky TS et al. Crystal structute of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221 (1994). (Pubitemid 24108837)
37. Kwok WW, Domeier ME, Raymond FC, Byers P, Nepom GT. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156, 2171-2177 (1996).
38. Kwok WW, Domeier ME, Johnson ML, Nepom GT, Koelie DM. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J. Exp. Med. 183, 1253-1258 (1996).
39. Quarsten H, Paulsen G, Johansen BH et al. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules. Int. Immunol. 10, 1229-1236 (1998). (Pubitemid 28362698)
40. *0303) . Hum. Immunol. 60, 1227-1236 (1999). (Pubitemid 30017505)
41. Kelly MA, Rayner ML, Mijovic CH, Barnett AH. Molecular aspects of type 1 diabetes. Mol. Pathol. 56, 1-10 (2003). (Pubitemid 36174224)
42. *0602 ab protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus. J. Immunol. 165, 3232-3238 (2000).
43. *04 disadvantage. Science 283, 1748-1752 (1999).
44. Stephens HAF. HIV-1 diversity versus HLA class I polymorphism. Trends Immunol. 26(1), 41-47 (2005). (Pubitemid 40051991)
45. Trachtenberg E, Korber B, Sollars C et al. Advantage of rare HLA supertype in HIV disease progression. Nat. Med. 9(7), 928-935 (2003). (Pubitemid 36889937)
46. Flores-Villanueva PO, Hendel H, Caillat-Zucman S et al. Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development. J. Immunol. 170, 1925-1929 (2003). (Pubitemid 36197411)
47. *57. AIDS 16, 961-972 (2002) (Pubitemid 34499419)
48. Steel CM et al. HLA haplotype A1B8DR3 as a risk factor for HIV related disease. Lancet 1, 1185-1188(1988).
49. O'Brien SJ, Nelson GW. Human genes that limit AIDS Nat. Gen. 36(6), 565-574 (2004) (Pubitemid 38715980)
50. Gao X, Bashinova A, Iversen AK et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat. Med. 11(12), 1290-1292. (2005) (Pubitemid 41752907)
51. Mehra NK, Kaur G. MHC based vaccination approaches: progress and perspectives. Expert Rev. Mol. Med. 5, 1-17 (2003).
52. *0211. Tissue Antigens. 57, 502-507 (2001). (Pubitemid 32783721)